Sequential, a leader in genomic testing from non-invasive human clinical samples, today announced the successful close of its first equity round, securing $3.5 million. The round was co-led by ...
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ...
Sequential hypothesis testing is a methodological framework that systematically evaluates data as it is acquired, enabling decisions to be made as soon as sufficient evidence is collected. This ...
In a hypothetical 1,000,000-member health plan, 2,066 Medicare-insured patients and 156 commercially insured patients were estimated to have mNSCLC and to be eligible for testing. Time-to-test results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results